Why the study?
Primary cardiac angiosarcoma is a rare malignant neoplasm with early metastasis and poor prognosis, and there are currently no guidelines or effective therapeutic strategies.
Palliative resection of primary cardiac angiosarcomas without adjuvant therapy may lead to early metastasis and death, highlighting the need for integrated multimodal treatment.
Answers are grounded in this paper and cite their sources.
Case report adds to sparse literature on cardiac angiosarcoma; leaves open need for prospective data to guide therapy.
RATIONALE: Primary cardiac angiosarcoma is a rare malignant cardiac neoplasm with early metastasis and poor prognosis. As there are currently no guidelines or effective therapeutic strategies, management of this condition depends on previous experiences of the clinician treating and the consideration of reported cases. PATIENT CONCERNS: A 65-year-old male presented to our department with a 4-day history of chest tightness, dyspnea, lower extremity weakness and occasional dizziness, and a transthoracic echo (TTE) revealed a right atrium occupying mass. DIAGNOSES: TTE showed right atrium occupation, and the post-operative histopathology showed the tumor to be a primary cardiac angiosarcoma. INTERVENTIONS: Right atrium tumor resection and right atrium reconstruction with a bovine pericardium were performed. OUTCOMES: The patient recovered from surgery and discharged but died 10 months after surgery because of complete resection was impossible and adjuvant therapy was not performed. LESSONS: Resection of primary cardiac angiosarcomas should be integrated with a combination of chemotherapy, radiotherapy, and targeted therapy based on tumor cell gene mutation and altered expression.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: